A number of drug-related issues will be explored by the EU drugs agency (EMCDDA) on June 4 in its annual overview of the European drug situation. Issues to be discussed include the latest drug market trends and factors driving them, the most recent developments in drug prevention, treatment and policy as well as new drugs detected in Europe over the last year and the consequences for those using them.

Central to the multilingual, multimedia information package is the European Drug Report 2015: Trends and Developments, a top-level analysis of the latest trends across the 28 EU Member States, Turkey and Norway. In print and online in 24 languages, the report examines: drug supply and the market; drug use and drug-related problems; and health and social responses to drug problems.

Accompanying the report will be Perspectives on drugs (PODs), online interactive articles providing insight into specific issues in the drugs field. The four themes in focus this year are: misuse of benzodiazepines among high-risk drug users; psychosocial interventions; drug consumption rooms; and heroin trafficking routes. The information package will be completed by the 2015 Statistical bulletin, containing the full European dataset underpinning the report, and Country overviews, providing national-level data and analyses.

An e-publication, including interactive maps and graphics, will be available in English. Audiovisual material will also be on offer.

Launch details

Date: Thursday 4 June 2015
Time: 10:00 Western European Time (Lisbon) (11:00 Central European Time)
Venue: Conference Centre, Praça Europa 4, Cais do Sodré, 1249-206, Lisbon
Press conference: With the presence of Dimitris Avramopoulos, European Commissioner responsible for Migration, Home Affairs and Citizenship; João Goulão, Chairman of the EMCDDA Management Board and Wolfgang Götz, EMCDDA Director.

Find out more
www.emcdda.europa.eu/edr2015